What Are Cocaine Substitutes and Their Dangers?

Cocaine substitutes fall into two broad categories: substances dealers mix into cocaine to stretch profits, and drugs people take instead of cocaine for a similar high. Both carry serious and often unpredictable health risks. Cutting agents like levamisole can destroy immune cells and cause skin to die; synthetic stimulants sold as alternatives can be many times more potent than cocaine itself; and fentanyl contamination of the cocaine supply has turned what users expect to be a stimulant experience into a potentially fatal opioid overdose. The landscape of these substances shifts constantly, which makes the dangers hard to pin down and even harder to test for.

What Gets Mixed Into Cocaine Before It Reaches You

Street cocaine is rarely pure. Dealers add cutting agents at every stage of the supply chain to increase weight and profit margins. A forensic analysis of seized cocaine samples found that levamisole was the most common adulterant, present in about 79% of samples, followed by phenacetin in roughly 19%, caffeine in about 12%, hydroxyzine in around 9%, and benzocaine in about 5%.¹ The amounts varied wildly: levamisole content ranged from a trace to nearly three-quarters of a sample’s weight, and benzocaine ranged from under 1% to more than half the powder.

These aren’t random fillers. Some are chosen because they mimic cocaine’s appearance or numbing effect on the gums, which users often use as a crude purity test. Local anesthetics like benzocaine and procaine produce that familiar numbing sensation, making heavily cut cocaine feel “real.” Others, like caffeine, add a mild stimulant buzz that masks low cocaine content. And levamisole, originally a veterinary dewormer, appears to have pharmacological effects that may complement or extend the cocaine high, which partly explains its staggering prevalence despite its toxic side effects.

Levamisole and What It Does to the Body

Levamisole deserves its own discussion because it shows up in such a large share of the cocaine supply and because its effects are uniquely dangerous. Once used as a human deworming drug and immune system modulator, it is now best known as a cocaine adulterant linked to a pattern of serious illness.²

Exposure to levamisole-adulterated cocaine can trigger a drop in white blood cells (neutropenia), low platelet counts, and inflammation of blood vessels. The mechanism is immune-driven: the body produces antibodies that attack its own neutrophils and damage blood vessel walls. This can cause a distinctive pattern of skin necrosis, often on the ears, nose, and cheeks, as well as on the extremities.³ The tissue death on the face can be disfiguring and is sometimes the first sign that brings a person to the emergency room. Because levamisole’s effects are autoimmune in nature, they can persist or recur even after cocaine use stops, making this one of the more insidious consequences of adulterated cocaine.

Local Anesthetics as Adulterants

Procaine, benzocaine, and lidocaine are among the most common local anesthetics added to cocaine. Their numbing properties are the obvious reason: if a buyer rubs powder on their gums and feels numbness, they assume it’s decent cocaine. But the health effects of these substances go beyond the gum test.

Research on how these adulterants interact with the body’s transport systems found that procaine and benzocaine block the same dopamine and norepinephrine transporters that cocaine targets, at concentrations that are physiologically relevant. In other words, they aren’t pharmacologically inert fillers. Procaine also interferes with organic cation transporters at potency comparable to or greater than cocaine itself.⁴ Among procaine-positive cocaine samples analyzed in one study, the average procaine content was around 153 milligrams per gram, with some samples containing over 700 milligrams per gram. At those levels, a person snorting what they think is cocaine is getting a substantial dose of a second drug that acts on many of the same systems, compounding cardiovascular strain and unpredictability. Lidocaine, by contrast, showed no significant effect on any of these transporters, making it relatively less dangerous as a cutting agent, though it still contributes to an unreliable product.

Synthetic Cathinones as Cocaine Alternatives

Synthetic cathinones, commonly known as “bath salts,” are lab-made stimulants that emerged as supposed legal alternatives to cocaine and amphetamines. They are derived from cathinone, a stimulant found in the khat plant, but their chemistry has been tweaked extensively to skirt drug laws. Mephedrone (4-MMC) was one of the first to gain wide popularity. When governments banned it, underground chemists synthesized close relatives like 3-MMC, and when that was restricted, 3-CMC and 2-MMC appeared. This game of regulatory whack-a-mole means new variants keep emerging.⁵

These substances are sometimes sold openly online, labeled “not for human consumption” or marketed as “research chemicals” to dodge regulations. A chemical analysis of products sold as “NRG-2” from different internet suppliers found they actually contained banned cathinones including 4-MEC and mephedrone, available in quantities up to a kilogram.⁶ The labeling bears no relationship to the actual contents. A buyer has essentially no idea what drug they’re getting, at what dose, or what else might be mixed in.

Why Synthetic Cathinones Can Be More Dangerous Than Cocaine

The assumption that a “substitute” is weaker than the real thing is wrong here. MDPV, one of the most studied synthetic cathinones and a key ingredient in many “bath salts” products, blocks dopamine uptake far more potently than cocaine does. Research found that MDPV also clears endogenous dopamine from the synapse with greater potency and efficacy than cocaine. Unlike some other cathinones such as mephedrone, MDPV is not a transporter substrate, meaning it acts purely as a blocker rather than also flooding the synapse with extra neurotransmitter. The result is an intense, cocaine-like stimulant effect that is stronger and longer-lasting.⁷

That extra potency translates directly into greater danger. The toxicity profile of synthetic cathinones includes agitation, aggression, psychosis, and sometimes bizarre and violent behavior.⁸ Alpha-PVP, also known as “flakka,” has been reported to produce frightening delusions, paranoid psychosis, and extreme agitation, with symptoms escalating rapidly beyond any intended euphoric effect.⁹

Repeated use raises the stakes further. A pattern of paranoid hallucinatory delirium has been documented with ongoing cathinone exposure. Some users develop a condition known as excited delirium, marked by extreme agitation, paranoia, and violent behavior. These episodes frequently involve dehydration, muscle breakdown, and kidney failure that can progress to multiple organ failure and death.¹⁰

Heart Damage From Stimulant Substitutes

Cocaine is already hard on the heart, causing blood vessel spasm, blood clots, and electrical disruption through sodium and potassium channel blockade.¹¹ The drugs sold as substitutes pile additional cardiovascular stress on top. Amphetamine-type stimulants and synthetic cathinones amplify the release of catecholamines (the body’s “fight or flight” chemicals), contributing to dangerous heart rhythms, reduced blood flow to the heart, and direct heart muscle injury.

Different cathinone variants cause different cardiac symptoms. Among 3-MMC users, rapid heart rate and agitation are the most common cardiovascular complaints. Mephedrone users more often report sweating, headaches, palpitations, and nausea. Animal studies suggest these drugs increase the heart’s stroke volume and contractility in ways that could cause cardiac ischemia. They also appear to impair mitochondrial function in heart cells, leading to oxidative stress and cell death, and to alter ion channel behavior in ways that promote abnormal rhythms.⁵ Long-term cardiovascular consequences of synthetic cathinones remain largely unknown, but researchers have suggested they may mirror the effects seen with chronic khat use: high blood pressure, coronary vasospasm, heart attack, stroke, and heart failure.

These cardiac risks are compounded when cocaine is adulterated with local anesthetics that themselves act on the same neurotransmitter systems, as described earlier. A user taking what they think is cocaine may effectively be consuming two or three cardioactive drugs at once, with no control over the dose of any of them.

Hyperthermia and Muscle Breakdown

Stimulant drugs, including cocaine and its substitutes, can cause dangerous rises in body temperature. These drugs trigger the release of neurotransmitters that ramp up heat production in skeletal muscle and brown fat tissue while simultaneously reducing the body’s ability to dissipate heat by altering blood flow to the skin.¹² In a hot environment like a dance club, or during vigorous physical activity, this combination can push core body temperature to life-threatening levels.

Severe hyperthermia sets off a cascade of problems. Skeletal muscle begins to break down, a condition called rhabdomyolysis, which floods the blood with proteins that can clog the kidneys. The excited delirium seen with synthetic cathinones frequently involves exactly this combination of extreme agitation, dehydration, muscle damage, and kidney failure.¹⁰ These patients arrive in emergency departments in crisis, and the window to intervene before organ failure becomes irreversible is narrow.

Fentanyl Contamination of the Cocaine Supply

Perhaps the most alarming development in recent years is the presence of fentanyl in cocaine. Unlike the adulterants already discussed, fentanyl is not added to mimic or enhance cocaine’s effects. It appears to enter the supply through shared equipment, cross-contamination during packaging, or deliberate addition for reasons that remain debated. Whatever the mechanism, the consequences are stark: fentanyl is a synthetic opioid roughly 50 to 100 times more potent than morphine by weight, and a dose invisible to the naked eye can be lethal.

Community-based drug checking services found fentanyl in roughly 15% of powder cocaine samples tested, with significant geographic variation.¹³ Epidemiological data from the mid-2010s showed that increased deaths involving fentanyl accounted for most of the rise in cocaine-involved fatal overdoses during that period.¹⁴ This means people who would never intentionally take an opioid are dying from opioid overdoses because their cocaine was contaminated. A stimulant user typically has no opioid tolerance, making even a small amount of fentanyl potentially fatal.

Synthetic Cocaine Analogues

Beyond cutting agents and cathinone-based substitutes, a third category exists: synthetic analogues of cocaine itself. These are molecules designed to mimic cocaine’s chemical structure while remaining technically legal in some jurisdictions. Dimethocaine, also called larocaine, is the most prominent example. It has been distributed as a “new psychoactive substance” and marketed as a legal high.¹⁵

The critical problem with dimethocaine and similar analogues is the complete absence of safety data. These compounds are consumed without any prior testing on their metabolism, their breakdown products in the body, or their toxic thresholds.¹⁶ A user is essentially running the first human trial on themselves, with no knowledge of what dose is too much, what organs might be affected, or how the drug interacts with alcohol, medications, or other substances. The marketed “legality” creates a false sense of safety that has nothing to do with actual pharmacological risk.

Why Standard Drug Tests Often Miss These Substances

If you or someone you know ends up in an emergency room after using what was thought to be cocaine, the standard urine drug screen may not detect the actual substance involved. There are several reasons for this. Many novel drugs and their metabolites don’t cross-react with the antibody-based tests designed to detect older, established drug classes. Identifying a new compound by mass spectrometry requires having its chemical signature already in the instrument’s library. And because illicit drugs are constantly rebranded on the street, the clinical history a patient provides may not point toward the right test.¹⁷

This detection gap has real consequences. Emergency physicians treating someone with severe agitation, psychosis, or heart rhythm problems may not know what drug they’re dealing with, and the treatments differ. Opioid reversal agents like naloxone can save a life if fentanyl is involved but do nothing for synthetic cathinone toxicity. Benzodiazepines are a mainstay for managing stimulant-related agitation, but the specific complications, such as levamisole-induced immune suppression, require entirely different interventions. When the drug screen comes back negative or only positive for cocaine, the treating team may not look for the additional substances that are actually driving the clinical picture.

Drug Checking as a Practical Harm Reduction Tool

Given that the contents of street drugs are unpredictable, one practical intervention that has gained traction is drug checking, where people can submit samples for analysis before using them. Research into these services has shown they influence behavior. In one evaluation, a high percentage of people who learned their sample contained an unexpected substance said they would not consume it.¹⁸

A pilot of the UK’s first community-based drug checking service provided results and harm reduction advice directly to over 200 users through tailored consultations. Among those who received results, about 38% said they would alert friends and acquaintances, roughly 35% planned to be more careful about mixing substances, around 28% intended to lower their dose, and about 7% said they would throw away further substances.¹⁹ These aren’t dramatic numbers, but in a landscape where people are dying from substances they didn’t know they were taking, even modest shifts in behavior can save lives. The broader value of drug checking lies in its early warning function: when a new adulterant or contaminant enters a local supply, testing services can flag it and push alerts through social media, community networks, and public health channels before a wave of hospital admissions hits.

The Regulatory Cat-and-Mouse Problem

One of the reasons cocaine substitutes remain so dangerous is the speed at which the market evolves. When a government bans one synthetic cathinone, another variant appears within months. The case of mephedrone and its successors illustrates this clearly: 3-MMC was synthesized around 2010 specifically to replace 4-MMC after it was criminalized in several countries. When 3-MMC itself came under restrictions, 3-CMC and 2-MMC entered the market.⁵ Each new compound comes with zero clinical data on its safety, its interactions, or its long-term effects. Pharmacologically, these variants share a family resemblance to amphetamine-type stimulants through structural substitutions, but small chemical tweaks can dramatically shift potency, duration, and side effect profiles in ways no one has tested.

This dynamic creates a situation where the newest substances on the market are always the least understood. Researchers studying mephedrone’s addiction potential have acknowledged that human data remain thin and that more research is needed to understand the safety and toxicity of these compounds. By the time enough research accumulates on one variant to guide clinical practice, the market has already moved on to the next. Users, emergency physicians, and forensic labs are all working with an information deficit that is built into the system.

1
PubMed. Determination of cutting agents in seized cocaine samples using GC-MS, GC-TMS and LC-MS/MS
2
PubMed. Vasculopathy and vasculitis associated with levamisole-adulterated cocaine: a systematic review
3
PubMed Central. Levamisole-adulterated cocaine induced skin necrosis of nose, ears, and extremities: Case report
4
Frontiers in Pharmacology. Health risks of cocaine adulteration: local anesthetics as modulators of monoamine and organic cation transporters
5
PubMed Central. Cardiotoxicity After Synthetic Cathinone Use; Two Cases, A Case Series and Scoping Review
6
BMJ Open. A chemical analysis examining the pharmacology of novel psychoactive substances freely available over the internet and their impact on public (ill)health
7
PubMed Central. Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive ‘bath salts’ products
8
PubMed Central. Synthetic cathinone abuse
9
PubMed Central. Flakka-Induced Prolonged Psychosis
10
General Hospital Psychiatry. Excited delirium following use of synthetic cathinones (bath salts)
11
PubMed. Acute cardiovascular complications of sympathomimetic recreational drug use
12
PubMed Central. The heat is on: Molecular mechanisms of drug-induced hyperthermia
13
PubMed Central. Prevalence of fentanyl in methamphetamine and cocaine samples collected by community-based drug checking services
14
PubMed Central. Increased Presence of Fentanyl in Cocaine-Involved Fatal Overdoses: Implications for Prevention
15
PubMed. Dimethocaine, a synthetic cocaine analogue: studies on its in-vivo metabolism and its detectability in urine by means of a rat model
16
PubMed. Dimethocaine, a synthetic cocaine derivative: studies on its in vitro metabolism catalyzed by P450s and NAT2
17
American Journal of Clinical Pathology. Newly Emerging Drugs of Abuse and Their Detection Methods: An ACLPS Critical Review
18
PubMed Central. Drug Checking as Strategy for Harm Reduction in Recreational Contests: Evaluation of Two Different Drug Analysis Methodologies
19
PubMed Central. City checking: Piloting the UK’s first community-based drug safety testing (drug checking) service in 2 city centres